Nothing New To Report: Green Screen Day…Update-1

Update: M&A will come back— Pfizer (PFE) buys Anacor (ANAC) for $5.2B. Now you see why inversions are not good for biotech stocks as PFE had to give up reverse merger and go for growth.

 

Last three posts are still on the mark. The 4% move today in XBI is encouraging ; the 6% move in REGN is also indicative of new money coming in.

Risk remains off.

Back from vacation with a new post on May 22.

No comments yet.

Leave a Reply